Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.
Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.
Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.
Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.
"Applying revolutionary technology in ways that improve the health of families is at the heart of Natera's mission."
- Matt Rabinowitz CEO and Co-Founder
Oncology testing
We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.
We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.
We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.
We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.
Genetica Now Offering Panorama™ NIPT in Switzerland via Natera's Constellation™ Software Platform
Natera, Inc., (NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that Genetica, a leading laboratory for prenatal diagnostics in...
Lab solutions
Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.
Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.
Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.
Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.
